Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update

Go back to Roivant Sciences Reports Financial Results for the First Quarter Ended June 30, 2022 and Provides Business Update

Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 16c

August 15, 2022 7:08 AM EDT

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.48), $0.16 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $7.18 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

... More